Metraipolis › archive › dc_cd81ead4d895

Network Pharmacology and In Vivo Validation Reveal Therapeutic Effects of Sutaehwan in Polycystic Ovary Syndrome by Modulating AMH-AMHR2 Signaling Pathway — Europe PMC PMID:41389252

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41389252
DOI
10.1007/s43032-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-07T16:11:02.637Z
SHA-256 of the archived text
81b922b860f51c5bc06aab80464bf0c0abf3c123f044ed5fb44047cf9171ed68
Stable URL of this page
https://metraipolis.com/documento/dc_cd81ead4d895

How to cite

Network Pharmacology and In Vivo Validation Reveal Therapeutic Effects of Sutaehwan in Polycystic Ovary Syndrome by Modulating AMH-AMHR2 Signaling Pathway — Europe PMC PMID:41389252 — Europe PMC (en), https://europepmc.org/article/MED/41389252 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd81ead4d895 (Metraipolis archive dc_cd81ead4d895, sha256 81b922b860f51c5bc06aab80464bf0c0abf3c123f044ed5fb44047cf9171ed68)
BibTeX
@misc{dccd81ead4d895,
  title = {Network Pharmacology and In Vivo Validation Reveal Therapeutic Effects of Sutaehwan in Polycystic Ovary Syndrome by Modulating AMH-AMHR2 Signaling Pathway — Europe PMC PMID:41389252},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41389252},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd81ead4d895; sha256 81b922b860f51c5bc06aab80464bf0c0abf3c123f044ed5fb44047cf9171ed68},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41389252. Agents can read the archived copy with the MCP tool read_document.